| SpectraBase Spectrum ID |
JJQG4TcDwRs |
| Name |
N,N-2-Butyl-ethyl-3,4-(difluoromethylene)dioxyamphetamine |
| Classification |
Amphetamine designer drug, stimulant, hallucinogenic |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
299.169685309 u |
| Formula |
C16H23F2NO2 |
| InChI |
InChI=1S/C16H23F2NO2/c1-5-11(3)19(6-2)12(4)9-13-7-8-14-15(10-13)21-16(17,18)20-14/h7-8,10-12H,5-6,9H2,1-4H3 |
| InChIKey |
YIWXGXYCKGBOPG-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
299.362 g/mol |
| Nominal Mass |
299 u |
| Quality |
996 |
| Retention Index |
1606 |
| SMILES |
C=12C(OC(O2)(F)F)=CC(CC(N(C(CC)C)CC)C)=CC1 |
| SPLASH |
splash10-004i-8900000000-b9b704305af10f619f39 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Amphetamine,N,N-2-butyl-ethyl-3,4-(difluoromethylene)dioxy
N-(1-(2,2-difluoro-1,3-benzodioxol-5-yl)propan-2-yl)-N-ethylbutan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_008225 |
